Programme
| Heures |
événement |
|
|
07:00 - 08:00
|
Paper free - Ecoresponsible congress - QR code will be available to get online access to the programm - QR code will be avalable to get one line access to the programm |
|
|
08:00 - 09:00
|
Accueil, Café |
|
|
09:00 - 09:30
|
Welcome speach - Welcome speach |
|
|
09:30 - 10:00
|
Tuning the ribosome in health and cancer - Anders Lund |
|
|
10:00 - 10:30
|
Eukaryotic Ribosomal RNA Modification - Denis Lafontaine |
|
|
10:30 - 11:00
|
Pause café |
|
|
11:00 - 11:30
|
Cap methyltransferase and c-Myc and ribosomal protein production - Victoria Cowling |
|
|
11:30 - 12:00
|
Global and transcript-specific analysis of translational control in disease - the eIF3 perspective - Leos Valasek |
|
|
12:00 - 12:30
|
Modelling ribosome dynamic in cancer cell - Jean-Charles Walter |
|
|
12:30 - 14:00
|
Déjeuner |
|
|
14:00 - 14:30
|
Lecture from Pr Norbert Ifrah, President of National Cancer Institute (INCa) - Pr Norbert Ifrah |
|
|
14:30 - 15:00
|
The role of eIF4B in dysregulation of mRNA translation in DLBCL - Anne Willis |
|
|
15:00 - 15:30
|
Translational control of pancreatic carcinogenesis - Yvan Martineau |
|
|
15:30 - 16:00
|
Ribosome alterations in cancer : impact on translational control and tumorigenesis - Jean-Jacques Diaz |
|
|
16:00 - 16:30
|
Pause café |
|
|
16:30 - 17:00
|
synthetic small molecules RNA ligands: scope and applications in cancer chemotherapy - Maria Duca |
|
|
17:00 - 17:30
|
Translational control of the stroma in cancer initiation and progression - Ola Larsson |
|
|
17:30 - 17:50
|
Estrogen receptor alpha controls gene expression via translational offsetting - Julie Lorent |
|
|
17:50 - 18:10
|
Targeting protein synthesis reshapes metabolism of malignant mesothelioma primary cells - Stefano Grosso |
|
|
18:10 - 18:30
|
Novel use of 5-Fluorouracil as readthrough inducer: Rescuing nonsense mutant TP53 in human tumor cells - Mireia Palomar-Siles |
|
|
18:30 - 18:50
|
Profiling cisplatin induced rearrangement of RNA-binding proteins on the CDKN1B/p27 3’UTR identifies modulators of drug sensitivity - André Gerber |
|
|
18:50 - 19:10
|
Identifying RNA binding proteins relevant for melanoma progression - Neus Mestre Farràs |
|
|
19:10 - 20:00
|
Drinks and Poster Session 1 - Drinks and Poster Session 1 |
|
| Heures |
événement |
|
|
07:00 - 08:00
|
Running session in Montpellier - Running session in Montpellier |
|
|
08:30 - 09:00
|
Pause café |
|
|
09:00 - 09:30
|
Codon-specific mRNA translation reprogramming in cancer - Pierre Close |
|
|
09:30 - 10:00
|
2'-O-Me in human rRNA and ribosome heterogeneity - Henrik Nielsen |
|
|
10:00 - 10:30
|
RNA modification and stem cell homeostasis - Michaela Frye |
|
|
10:30 - 11:00
|
Pause café |
|
|
11:00 - 11:30
|
RNA methylation shapes cancer cell fate - Alexandre David |
|
|
11:30 - 12:00
|
to be announced - Martin Bushell |
|
|
12:00 - 12:30
|
A translatome view of p53-dependent apoptosis - Alberto Inga |
|
|
12:30 - 14:00
|
Déjeuner |
|
|
14:00 - 14:30
|
Translational control of the tumor stress response confers metastatic capacity - Poul Sorensen |
|
|
14:30 - 15:00
|
Cellular Responses to Chronic Stress - Maria Hatzoglou |
|
|
15:00 - 15:30
|
Cap independent translation and cancer - Romao Luisa |
|
|
15:30 - 16:00
|
Lighting up stress induced changes in translation - David Tollervey |
|
|
16:00 - 17:00
|
Pause café et Poster Session |
|
|
17:00 - 17:30
|
poly(A) RNA turnover and oncogenic transformation - Georg Stoecklin |
|
|
17:30 - 17:50
|
Sponsor presentation: Qiagen - Hélène Bauby |
|
|
17:50 - 18:10
|
Sponsor presentation: PPC - Christophe Hirtz |
|
|
18:10 - 18:30
|
Towards the understanding of a dynamic 2’-O-methylation in the 18S rRNA - Kasper Andersen |
|
|
18:30 - 18:50
|
HnRNP H/F drive RNA G-quadruplex-mediated translation linked to genomic instability and therapy resistance in glioblastoma - Pauline Herviou |
|
|
18:50 - 19:10
|
Translation initiation factor INT6/eIF3e is a target for human glioma cell radio-sensitization through regulation of specific mRNA translation - Juliette Bertorello |
|
|
19:30 - 23:55
|
Diner de Gala |
|
| Heures |
événement |
|
|
08:30 - 09:00
|
Pause café |
|
|
09:00 - 09:30
|
Linking leukaemia with defective ribosome assembly - Alan Warren |
|
|
09:30 - 10:00
|
UNR/CSDE1 in cancer progression and suppression - Fatima Gebauer |
|
|
10:00 - 10:30
|
LARP1 as a therapeutic target in ovarian cancer - Sarah Blagden |
|
|
10:30 - 11:00
|
Pause café |
|
|
11:00 - 11:30
|
CPEB1/CPEB4 balance controls skin homeostasis and squamous Cell Carcinoma development - Raul Mendez |
|
|
11:30 - 12:00
|
Targeting translation in colorectal cancer - Owen Sansom |
|
|
12:00 - 12:30
|
Conclusion, highlights and outcomes - Conclusion |
|
|
12:30 - 14:00
|
Déjeuner |
|
|
12:30 - 14:00
|
OFF SESSION lunch with PIs (European Network) - OFF SESSION lunch with PIs (European Network) |
|
|
14:00 - 16:00
|
OPEN SESSION with stakeholders (patient associations, industrials, clinicians) - OPEN SESSION with stakeholders (patient associations, industrials, cliniciustrials, clinicians) |
|
|
